Atlas Trials

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Clinical trial NCT05733000 · RECRUITING

Trial details

NCT number
NCT05733000
Sponsor
Northwestern University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract CarcinomaAdvanced Colorectal CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Lung AdenocarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian CarcinomaAdvanced Pancreatic CarcinomaAdvanced Urothelial CarcinomaClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Metastatic Biliary Tract CarcinomaMetastatic Colorectal Carcinoma
Start date
2023-03-08
Primary completion
2028-01-04
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.